Suppr超能文献

将肿瘤结构重建为类器官。

Reconstructing the tumor architecture into organoids.

机构信息

Department of Bioengineering, California NanoSystems Institute and Center for Minimally Invasive Therapeutics, University of California, Los Angeles, Los Angeles, CA 90095, USA; School of Pharmacy, Xi'an Jiaotong University, Xi'an 710061, China.

Department of Bioengineering, California NanoSystems Institute and Center for Minimally Invasive Therapeutics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48109, USA.

出版信息

Adv Drug Deliv Rev. 2021 Sep;176:113839. doi: 10.1016/j.addr.2021.113839. Epub 2021 Jun 19.

Abstract

Cancer remains a leading health burden worldwide. One of the challenges hindering cancer therapy development is the substantial discrepancies between the existing cancer models and the tumor microenvironment (TME) of human patients. Constructing tumor organoids represents an emerging approach to recapitulate the pathophysiological features of the TME in vitro. Over the past decade, various approaches have been demonstrated to engineer tumor organoids as in vitro cancer models, such as incorporating multiple cellular populations, reconstructing biophysical and chemical traits, and even recapitulating structural features. In this review, we focus on engineering approaches for building tumor organoids, including biomaterial-based, microfabrication-assisted, and synthetic biology-facilitated strategies. Furthermore, we summarize the applications of engineered tumor organoids in basic cancer research, cancer drug discovery, and personalized medicine. We also discuss the challenges and future opportunities in using tumor organoids for broader applications.

摘要

癌症仍然是全球主要的健康负担之一。阻碍癌症治疗发展的一个挑战是现有的癌症模型与人类患者的肿瘤微环境(TME)之间存在很大差异。构建肿瘤类器官是体外重现 TME 病理生理特征的一种新兴方法。在过去的十年中,已经证明了多种方法可以将肿瘤类器官作为体外癌症模型进行工程设计,例如纳入多种细胞群体、重建生物物理和化学特性,甚至重现结构特征。在这篇综述中,我们重点介绍了构建肿瘤类器官的工程方法,包括基于生物材料、微制造辅助和合成生物学辅助的策略。此外,我们总结了工程化肿瘤类器官在基础癌症研究、癌症药物发现和个性化医学中的应用。我们还讨论了使用肿瘤类器官进行更广泛应用所面临的挑战和未来机遇。

相似文献

1
Reconstructing the tumor architecture into organoids.将肿瘤结构重建为类器官。
Adv Drug Deliv Rev. 2021 Sep;176:113839. doi: 10.1016/j.addr.2021.113839. Epub 2021 Jun 19.
4
Organoids: approaches and utility in cancer research.类器官:在癌症研究中的方法和应用。
Chin Med J (Engl). 2023 Aug 5;136(15):1783-1793. doi: 10.1097/CM9.0000000000002477.
5
Organ-on-Chip platforms to study tumor evolution and chemosensitivity.芯片上器官平台研究肿瘤进化和化疗敏感性。
Biochim Biophys Acta Rev Cancer. 2022 May;1877(3):188717. doi: 10.1016/j.bbcan.2022.188717. Epub 2022 Mar 16.
6
Patient-derived organoids as a model for tumor research.患者来源的类器官作为肿瘤研究的模型。
Prog Mol Biol Transl Sci. 2022;189(1):259-326. doi: 10.1016/bs.pmbts.2022.03.004. Epub 2022 Apr 22.
8
Organoids: An intermediate modeling platform in precision oncology.类器官:精准肿瘤学中的中间建模平台。
Cancer Lett. 2018 Feb 1;414:174-180. doi: 10.1016/j.canlet.2017.11.021. Epub 2017 Nov 22.

引用本文的文献

1
Organoid technology in cervical cancer research.宫颈癌研究中的类器官技术。
Am J Cancer Res. 2025 May 15;15(5):1988-2003. doi: 10.62347/FNTD1712. eCollection 2025.
2
Microfabricated Organ-Specific Models of Tumor Microenvironments.肿瘤微环境的微制造器官特异性模型
Annu Rev Biomed Eng. 2025 May;27(1):307-333. doi: 10.1146/annurev-bioeng-110222-103522.
7
Breaking the mold: 3D cell cultures reshaping the future of cancer research.打破常规:3D细胞培养重塑癌症研究的未来。
Front Cell Dev Biol. 2024 Nov 26;12:1507388. doi: 10.3389/fcell.2024.1507388. eCollection 2024.
8
Advancing cancer research through organoid technology.通过类器官技术推进癌症研究。
J Transl Med. 2024 Nov 8;22(1):1007. doi: 10.1186/s12967-024-05824-1.

本文引用的文献

1
Microtechnology-based methods for organoid models.基于微技术的类器官模型构建方法。
Microsyst Nanoeng. 2020 Oct 5;6:76. doi: 10.1038/s41378-020-00185-3. eCollection 2020.
10
Drug screening model meets cancer organoid technology.药物筛选模型与癌症类器官技术相结合。
Transl Oncol. 2020 Nov;13(11):100840. doi: 10.1016/j.tranon.2020.100840. Epub 2020 Aug 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验